Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

Clinical trial NCT03428802 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03428802
Sponsor: Rutgers, The State University of New Jersey
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

BRCA1 Gene Mutation BRCA2 Gene Mutation Locally Advanced Solid Neoplasm Metastatic Malignant Solid Neoplasm POLD1 Gene Mutation POLE Gene Mutation Recurrent Malignant Solid Neoplasm Recurrent Ovarian Carcinoma Stage III Breast Cancer AJCC v7 Stage III Ovarian Cancer AJCC v8 Stage IIIA Breast Cancer AJCC v7 Stage IIIA Ovarian Cancer AJCC v8

Start date: 2018-03-08
Primary completion: 2024-11-24
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.